Showing results (721-730 of 795) with videos related to
Sort By:
Pageof 80
Psychological Medicine|April 29, 2020
Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescenceClaire Mokrysz, Natacha D C Shaban, Tom P Freeman, et al.Psychopharmacology|September 3, 2016
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypothesesWill Lawn, Tom P Freeman, Rebecca A Pope, et al.Stem Cell Reports|June 14, 2023
Nutritional requirements of human induced pluripotent stem cellsDavi M Lyra-Leite, Raymond R Copley, Phillip P Freeman, et al.Psychotherapy and Psychosomatics|September 4, 2019
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive DisorderTa-Wei Guu, David Mischoulon, Jerome Sarris, et al.Journal of Affective Disorders|September 9, 2019
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Rebecca S Hock, et al.BMJ Mental Health|August 26, 2025
Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology?Edoardo Spinazzola, Hannah Degen, Isabelle Austin-Zimmerman, et al.The International Journal of Neuropsychopharmacology|October 13, 2017
Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and EmotionTom P Freeman, Rebecca A Pope, Matthew B Wall, et al.Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.The Journal of Clinical Psychiatry|November 16, 2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine StudyAnna Feeney, Bettina B Hoeppner, Marlene P Freeman, et al.Journal of Affective Disorders|February 25, 2020
A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorderTa-Wei Guu, David Mischoulon, Jerome Sarris, et al.Pageof 80